Comparison to Statins Today, nearly 50 million Americans take statins, yet cardiovascular disease has not been diminished after decades of so called treatments
In this guide, well break down how they compareacross effectiveness, dosing, convenience, cost, side effects, and moreso you can feel confident in choosing the option that fits you best
Pomalyst (pomalidomide) Disease area(s): Oncology/hematology Manufacturer(s): Bristol Myers Squibb 2024 Sales (USD): $3.55 billion Why it sold so well: Bristol Myers Squibbs blood cancer drug Pomalyst netted global sales of $3.55 billion, an increase of 3% from the previous year and accounted for approximately 7.3% of the companys total revenue of $48.3 billion in 2024
They argue that the shortage of Ozempic and Wegovy gives them the right to make and market compounded equivalents
Theyre also mostly prescribed to treat diabetes instead of obesity, Anekwe added